AAPG Latest Press Releases

-- November 4, 2026 --

Ascentage Pharma to Present Data from Multiple Trials, Including an Oral Presentation of APG-5918 at ASH 2026 Globe Newswire 6:30 PM

-- November 3, 2026 --

Ascentage Pharma to Participate in Two Upcoming Investor Conferences in London Globe Newswire 7:30 AM

-- October 20, 2026 --

Ascentage Pharma's Lisaftoclax Granted Breakthrough Therapy Designation in China for Treatment-Nave CLL/SLL Globe Newswire 7:30 PM

-- September 2, 2026 --

Ascentage Pharma to Participate in Four Upcoming Investor Conferences Globe Newswire 8:00 AM

-- August 19, 2026 --

Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates Globe Newswire 7:00 PM

-- August 13, 2026 --

Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit Globe Newswire 8:00 AM

-- August 5, 2026 --

CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026 Globe Newswire 9:07 AM

Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026 Globe Newswire 8:00 AM

-- August 2, 2026 --

Ascentage Pharma Appoints Dr. Faial Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer Globe Newswire 7:30 PM

-- July 26, 2026 --

Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026 Globe Newswire 7:30 PM

-- June 14, 2026 --

Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress Globe Newswire 7:30 PM

Market Data Delayed 15 Minutes